Labeling and artwork are vital components of the life sciences industry, as they ensure regulatory compliance and can be used in packaging, online, and in the supply chain. Failure to comply with Good Manufacturing Practice (GMP) requirements, which include proofreading and change control, can lead to errors in labeling content, resulting in significant fines and drug recalls.
In this viewpoint, we examine the evolving labeling and artwork landscape for the biopharmaceutical and medical device industries, current market trends, and the provider landscape, along with possible synergies.
Industry
Life Sciences BPS
Geography
Global
Contents
In this report, we examine:
The evolving labeling and artwork landscape for biopharma and medical devices industries
The rapid adoption of digital services across the themes of connected care, supply chain visibility, manufacturing 4.0, omnichannel customer experience, and digital surgery has driven MedTech growth. This increased adoption is aimed at enhancing oper…
